We previously reported decreased deaminase activity and fewer APOBEC signature mutations upon shRNA-mediated A3B knockdown in myeloma cells, suggesting that, among APOBECs, A3B plays a major role in cytidine deamination-related mutagenesis in myeloma cells7. Here, APOBEC3B is linked to plasma cell myeloma.